Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL1HJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,502
Award facts
- Contract value 100% obligated
- $14,502.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,502.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide injection), with completion targeted for January 30, 2026. This is a non-set-aside, competitively awarded contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant federal procurement responsibilities through its parent company Cencora, Inc. The company's portfolio includes delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This contract award demonstrates the contractor's continued capability to meet federal medical supply requirements through open competition, consistent with the firm fixed-price delivery order model used for pharmaceutical procurement within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FL1HJ?
SPE2DR26FL1HJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FL1HJ worth?
The government has obligated $14,502 on SPE2DR26FL1HJ.
Is contract SPE2DR26FL1HJ an order under another contract?
Yes. SPE2DR26FL1HJ is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1HJ competed?
The extent of competition for SPE2DR26FL1HJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award